|
|
Substance Name: Meropenem [INN]
RN: 96036-03-2
UNII: YOP6PX0BAO
InChIKey: DMJNNHOOLUXYBV-PQTSNVLCSA-N
Note
- Broad-spectrum antimicrobial.
Molecular Formula
- C17-H25-N3-O5-S
Molecular Weight
- 383.4665
Classification Codes
- Anti-Bacterial Agents
- Anti-Infective Agents
- Drug / Therapeutic Agent
- Reproductive Effect
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Results Name
- Meropenem [INN]
Name of Substance
- Meropenem
- Meropenem anhydrous
- Meropenem [INN]
Synonyms
- Antibiotic SM 7338
- BRN 6940582
- HSDB 8019
- ICI 194660
- Meropenem
- Meropenemum
- Meropenemum [INN-Latin]
- Merrem
- Merrem I.V.
- SM 7338
- UNII-YOP6PX0BAO
Systematic Names
- 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(((3S,5S)-5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-, (4R,5S,6S)-
- 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4R-(3(S*,5S*),4-alpha,5-beta,6-beta(R*)))-
Registry Numbers
CAS Registry Number
- 96036-03-2
FDA UNII
- YOP6PX0BAO
System Generated Number
- 0096036032
Structure Descriptors
InChI
1S/C17H25N3O5S/c1-7-12-11(8(2)21)16(23)20(12)13(17(24)25)14(7)26-9-5-10(18-6-9)15(22)19(3)4/h7-12,18,21H,5-6H2,1-4H3,(H,24,25)/t7-,8-,9+,10+,11-,12-/m1/s1InChIKey
DMJNNHOOLUXYBV-PQTSNVLCSA-NSmiles
C[C@@H]1[C@@H]2[C@H](C(=O)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LDLo | intravenous | 2gm/kg (2000mg/kg) | LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Chemotherapy Vol. 40(Suppl, |
mouse | LD50 | intravenous | 2650mg/kg (2650mg/kg) | BEHAVIORAL: ATAXIA BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Chemotherapy Vol. 40(Suppl, |
mouse | LD50 | oral | > 5gm/kg (5000mg/kg) | Chemotherapy Vol. 40(Suppl, | |
mouse | LD50 | subcutaneous | > 5gm/kg (5000mg/kg) | Chemotherapy Vol. 40(Suppl, | |
rat | LD50 | intravenous | 2850mg/kg (2850mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Chemotherapy Vol. 40(Suppl, |
rat | LD50 | oral | > 5gm/kg (5000mg/kg) | Chemotherapy Vol. 40(Suppl, | |
rat | LD50 | subcutaneous | > 5gm/kg (5000mg/kg) | Chemotherapy Vol. 40(Suppl, |